Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular biomolecules in Protoporphyrin IX (PpIX)-accumulating cells refer to the diverse set of intracellular targets—including membrane lipids, structural proteins, enzymes, and nucleic acids—that are damaged during photodynamic therapy (PDT). PpIX is an endogenous chemosensitizer that accumulates preferentially in malignant cells following the administration of 5-aminolevulinic acid (5-ALA) due to the high metabolic demand and enzymatic imbalances characteristic of cancer, such as downregulated ferrochelatase (Kennedy & Pottier, 1990). Upon excitation by specific light wavelengths, PpIX facilitates a Type II photochemical reaction, transferring energy to ground-state molecular oxygen to produce highly reactive singlet oxygen (Wachowska et al., 2011). This singlet oxygen induces rapid, non-specific oxidative damage to the surrounding cellular biomolecules, leading to the loss of organelle integrity, particularly in the mitochondria and lysosomes, which triggers apoptotic or necrotic cell death (National Cancer Institute). Clinically, this mechanism is exploited for both the fluorescence-guided resection of tumors and the targeted destruction of lesions in diseases such as glioblastoma, basal cell carcinoma, and actinic keratosis (StatPearls). The therapeutic window is achieved not through molecular specificity for a single protein, but through the selective metabolic accumulation of the photosensitizer in target tissues (PubChem).
Photosensitization-induced generation of singlet oxygen leading to non-specific oxidative damage of cellular components.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular biomolecules in Protoporphyrin IX (PpIX)-accumulating cells.